Moolec Science SA cash flow statement

In fiscal 2025, Moolec Science SA's operations generated $3.6m of cash; it spent $5.7m on capital projects, leaving free cash flow of −$2.0m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Moolec Science SA: cash flow statement, annual
Fiscal year	2023Jun 2023	2024Jun 2024	2025Jun 2025
Cash from operations	−41	40	4
Depreciation and amortisation	0	0	—
Stock-based pay	3	14	4
Capital spending	11	10	6
Free cash flow	−53	30	−2
Free cash flow after stock pay	−56	15	−6

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: IOVA vs MLEC ARVN vs MLEC ADPT vs MLEC

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Moolec Science SA's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Moolec Science SA.